These documents are the advice of the Advisory Committee on Releases to the Environment (ACRE) to government on an application from Rothamsted Research to carry out a trial of Camelina sativa, which has been genetically modified to produce omega-3 fatty acids, wax esters, and a pigment in its seed.
The committee advised that the risks to human health and the environment from this trial are extremely low.
Follow this news feed: DEFRA